Sponsored Links

CEL-SCI Corporation Study Shows LEAPS Dendritic Cell Therapy To Be Effective In Treating H1N1 Virus PDF Print E-mail
Medical News - Flu Cold SARS
CEL-SCI Corporation (NYSE Amex: CVM) today announced the positive results of efficacy studies in mice of L.E.A.P.S.TM (Ligand Epitope Antigen Presentation System) H1N1 activated dendritic cells (DCs) to treat the H1N1 virus. Scientists found that H1N1-infected mice treated with LEAPS-H1N1 DCs showed a survival advantage over mice treated with control DCs...

Read more: Flu / Cold / SARS News From Medical News Today